Clinical Characteristics of Pars Tensa Cholesteatoma: A Comparative Study of Area-Based Classification Systems Proposed by the Japanese Otological Society and the European Academy of Otology - Neuro-Otology.


Journal

The journal of international advanced otology
ISSN: 2148-3817
Titre abrégé: J Int Adv Otol
Pays: Turkey
ID NLM: 101522982

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 10 7 2019
medline: 6 2 2020
entrez: 10 7 2019
Statut: ppublish

Résumé

To assess the clinical characteristics of extent patterns in pars tensa cholesteatoma. This was a retrospective chart review. Forty-four patients with pars tensa cholesteatoma who underwent primary surgery at a tertiary academic medical center were included. The main outcomes measured were sex, age, clinical background, and stage classification of pars tensa cholesteatoma (including the extent of cholesteatoma and involvement of the sinus tympani) according to two staging classifications: criteria advocated by the Japanese Otological Society (JOS) and those advocated by the European Academy of Otology and Neuro-Otology (EAONO)/JOS joint consensus statements. The mean patient age ± standard deviation was 38.4±19.6 years. The patients comprised 19 men and 25 women. According to the JOS classification, 18 ears (40.9%) were classified as stage I, 22 (50.0%) as stage II, and 4 (9.1%) as stage III. According to the EAONO/JOS joint consensus statements, 14 ears (31.8%) were classified as stage I, 26 (59.1%) as stage II, and 4 (9.1%) as stage III. Fourteen ears (31.8%) demonstrated involvement of the sinus tympani. Four ears (9.1%) that were originally categorized as stage I cholesteatoma by the JOS criteria showed sinus tympani invasion and were subsequently categorized as stage II according to the EAONO/JOS criteria. We determined the clinical characteristics of pars tensa cholesteatoma based on the novel and well-defined classification criteria. Further studies including long-term outcomes are necessary to demonstrate the clinical relevance of the discrepancy between the two criteria with respect to involvement of the sinus tympani.

Identifiants

pubmed: 31287432
doi: 10.5152/iao.2019.6349
pmc: PMC6750777
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

184-188

Références

Clin Otolaryngol Allied Sci. 1999 Aug;24(4):355-9
pubmed: 10472474
Acta Otolaryngol. 1999;119(5):568-72
pubmed: 10478597
Laryngoscope. 2003 Mar;113(3):443-8
pubmed: 12616194
Otolaryngol Head Neck Surg. 2003 Nov;129(5):490-6
pubmed: 14595271
Eur Arch Otorhinolaryngol. 2007 Oct;264(10):1137-43
pubmed: 17534638
Otol Neurotol. 2011 Aug;32(6):992-5
pubmed: 21725267
Braz J Otorhinolaryngol. 2011 Jun;77(3):341-7
pubmed: 21739009
Otol Neurotol. 2012 Jul;33(5):765-8
pubmed: 22569150
Auris Nasus Larynx. 2014 Oct;41(5):417-21
pubmed: 24933709
J Int Adv Otol. 2015 Apr;11(1):81-7
pubmed: 26223725
JAMA Otolaryngol Head Neck Surg. 2016 Feb;142(2):168-72
pubmed: 26747599
Auris Nasus Larynx. 2017 Apr;44(2):135-140
pubmed: 27616746
J Int Adv Otol. 2017 Apr;13(1):1-8
pubmed: 28059056
Auris Nasus Larynx. 2018 Feb;45(1):45-50
pubmed: 28274504
J Int Adv Otol. 2017 Aug;13(2):266-271
pubmed: 28274903
Otol Neurotol. 2017 Jun;38(5):e41-e45
pubmed: 28333776
Am J Otol. 1996 Nov;17(6):823-6
pubmed: 8915407

Auteurs

Masaomi Motegi (M)

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Yutaka Yamamoto (Y)

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Takeshi Tada (T)

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Masahiro Takahashi (M)

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Sayaka Sampei (S)

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Hiromi Sano (H)

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Tsunetaro Morino (T)

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Manabu Komori (M)

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Masahiro Miura (M)

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Kazuhisa Yamamoto (K)

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Yuichiro Yaguchi (Y)

Department of Otorhinolaryngology, St. Marianna University School of Medicine, Kanagawa, Japan.

Yuika Sakurai (Y)

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Hiromi Kojima (H)

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH